Recent Deals

Celgene Acquisition by Bristol-Myers Squibb

Celgene Corporation (NASDAQ: CELG) and Bristol-Myers Squibb Company (NYSE: BMY), a Delaware corporation, agreed to a Plan of Merger, dated as of January 2, 2019.

Morrow Sodali served as proxy solicitor for this transaction.

Find more information here

Topics

Celgene Acquisition by Bristol-Myers Squibb

Topics

Celgene Corporation (NASDAQ: CELG) and Bristol-Myers Squibb Company (NYSE: BMY), a Delaware corporation, agreed to a Plan of Merger, dated as of January 2, 2019.

Morrow Sodali served as proxy solicitor for this transaction.

Find more information here